Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Built for high reliability, world's only lumenless defibrillation lead approved for placement in the...
Source route
Continue on news.medtronic.com
Leave the platform to read the original full article on the publisher site.
Source: Medtronic News
Scope: Devices
Related coverage
More related coverage
Financials & Filings
Annual Results & Proxy Statements
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures
Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug...